Species Distribution and Antifungal Susceptibilities of Yeast Clinical Isolates from Three Hospitals in Korea, 2001 to 2007
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background : We utilized results from the ARTEMIS DISK Global Antifungal Surveillance Program to evaluate the species distribution and fluconazole and voriconazole susceptibilities of yeast isolates from clinical specimens in South Korea from 2001 to 2007. Methods : Data were collected on 5,665 yeast isolates from all body sites at three locations. All investigators tested clinical yeast isolates using the CLSI M44-A disk diffusion method. Test plates were automatically read and results were recorded using the BIOMIC image analysis plate reader system (Giles Scientific, USA). Species, drug, zone diameter, susceptibility category, and quality control results were collected quarterly via e-mail for analysis. Results: Candida albicans was the most common isolate, but a progressive increase in non-C. albicans Candida and noncandidal yeast species has been observed in recent years. The overall percentages of isolates in each category (susceptible, susceptible dose dependent, and resistant)were 98.8%, 0.5%, and 0.7% and 99.2%, 0.2%, and 0.6% for fluconazole and voriconazole, respectively. Candida of 3 species exhibited decreased susceptibility to fluconazole (<90% S) in the order of that seen with the resistant (R) species: C. krusei, C. guilliermondii, and C. glabrata. Emerging resistance to fluconazole or voriconazole was documented among isolates of Cryptococcus neoformans, Trichosporon spp., and Rhodotorula spp. Conclusions : The species distribution and antifungal susceptibilities of yeasts may differ according to specimen type, testing method, hospital, and geographic region. Therefore, further largescaled, long-term surveillance studies are needed to isolate yeasts and to confirm the species distribution and antifungal susceptibilities of yeast isolates from clinical specimens in Korea. (Korean J Lab Med 2010;30:364-72)
Abstract
Background : We utilized results from the ARTEMIS DISK Global Antifungal Surveillance Program to evaluate the species distribution and fluconazole and voriconazole susceptibilities of yeast isolates from clinical specimens in South Korea from 2001 to 2007. Methods : Data were collected on 5,665 yeast isolates from all body sites at three locations. All investigators tested clinical yeast isolates using the CLSI M44-A disk diffusion method. Test plates were automatically read and results were recorded using the BIOMIC image analysis plate reader system (Giles Scientific, USA). Species, drug, zone diameter, susceptibility category, and quality control results were collected quarterly via e-mail for analysis. Results: Candida albicans was the most common isolate, but a progressive increase in non-C. albicans Candida and noncandidal yeast species has been observed in recent years. The overall percentages of isolates in each category (susceptible, susceptible dose dependent, and resistant)were 98.8%, 0.5%, and 0.7% and 99.2%, 0.2%, and 0.6% for fluconazole and voriconazole, respectively. Candida of 3 species exhibited decreased susceptibility to fluconazole (<90% S) in the order of that seen with the resistant (R) species: C. krusei, C. guilliermondii, and C. glabrata. Emerging resistance to fluconazole or voriconazole was documented among isolates of Cryptococcus neoformans, Trichosporon spp., and Rhodotorula spp. Conclusions : The species distribution and antifungal susceptibilities of yeasts may differ according to specimen type, testing method, hospital, and geographic region. Therefore, further largescaled, long-term surveillance studies are needed to isolate yeasts and to confirm the species distribution and antifungal susceptibilities of yeast isolates from clinical specimens in Korea. (Korean J Lab Med 2010;30:364-72)
참고문헌 (19)
- 채명종, "최근 8년간 혈액에서 분리된 Candida 균종과 항진균제 감수성", The Korean Journal of Laboratory Medicine, 23(5), pp.329~335 (2003), 대한진단검사의학회
- 신정환, "최근 6년간 임상검체에서 분리된 칸디다의 균종 분포와 항진균제 감수성", 대한임상미생물학회지, 7, pp.164~170 (2004)
- Lee MK, "Susceptibility and trailing growth of Candida albicans to fluconazole:results of a Korean multicentre study", Mycoses, 50, pp.148~149 (2007)
- 이진솔, "Species Distribution and Susceptibility to Azole Antifungals of Candida Bloodstream Isolates from Eight University Hospitals in Korea", Yonsei Medical Journal, 48(5), pp.779~786 (2007), 연세대학교의과대학
- Kim SH, "The relationship between antifungal usage and antifungal susceptibility in clinical isolates of Candida: a multicenter Korean study", Med Mycol, 4, pp.296~304 (2009)
- Yoo JI, "National surveillance of antifungal susceptibility of Candida species in South Korean hospitals", Med Mycol, 47, pp.554~558 (2009)
- Pfaller MA, "Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-yr analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing", J Clin Microbiol, 43, pp.5848~5859 (2005)
- Pfaller MA, "Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-yr analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing", J Clin Microbiol, 45, pp.1735~1745 (2007)
- Pfaller MA, "Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-yr analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing", J Clin Microbiol, 47, pp.117~123 (2009)
- Isenberg HD, "Clinical microbiology procedures handbook. 2nd ed" (2003), ASM Press
- Sheehan DJ, "National Committee for Clinical Laboratory Standards. Method for antifungal disk diffusion susceptibility testing of yeasts: approved guideline. M44-A" (2004), NCCLS
- Hazen KC, "Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-yr global evaluation using disk diffusion", J Clin Microbiol, 41, pp.5623~5632 (2003)
- 강병기, "혈액에서 배양된 세균과 진균의 균종 및 항균제 감수성의 추이 (1986-1996)", 대한임상병리학회지, 18, pp.57~64 (1998)
- 어영, "최근 혈액에서 분리되는 칸디다 균종의 분리추이와 항진균제 감수성", 감염, 33, pp.186~193 (2001)
- 김영아, "건강 성인의 구강에서 분리되는 효모형 진균", 대한임상병리학회지, 20, pp.30~35 (2000)
- 이시헌, "당뇨환자에서 구강내 칸디다균의 분포에 대한 조사", 대한의진균학회지, 7(3), pp.139~148 (2002), 대한의진균학회1
- 최진혁, "표재성 피부칸디다증에서 칸디다 균종의 분리 및 동정", 대한피부과학회지, 40(10), pp.1188~1194 (2002), 대한피부과학회
- Pfaller MA, "Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program", J Clin Microbiol, 42, pp.3607~3612 (2004)
- Pfaller MA, "Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program", Diagn Microbiol Infect Dis, 65, pp.27~34 (2009)